Challenges and Opportunities Confronting the Botanical Dietary Supplement Industry†
- 28 June 2002
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 65 (7), 1073-1084
- https://doi.org/10.1021/np0200515
Abstract
The intent of this review is to identify and characterize the scientific challenges confronting the botanical dietary supplements industry, explore opposing sides of some controversial issues, and outline an agenda for addressing the more acute problems. The issues posing the greatest challenge to the industry center on quality, safety, and benefit. A key conclusion is that development of the scientific base of the industry has not kept pace with the rapid expansion of the manufacturing and marketing components. Recommendations for addressing the existing challenges are offered.Keywords
This publication has 76 references indexed in Scilit:
- Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trialInternational Journal of Obesity, 2002
- In Vitro Binding Studies with Two Hypericum Perforatum Extracts - Hyperforin, Hypericin and Biapigenin - on 5-HT6, 5-HT7, GABAA/Benzodiazepine, Sigma, NPY-Y1 /Y2 Receptors and Dopamine TransportersPharmacopsychiatry, 2001
- Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)New England Journal of Medicine, 2000
- Proposed Guidelines for Commercial Collection of Medicinal Plant MaterialJournal of Herbs, Spices & Medicinal Plants, 2000
- A New Heterocyclization Product of Adhyperforin from Hypericum perforatum (St. John's Wort)Molecules, 2000
- Plant biotechnology: Moral dilemmas: Editorial overviewCurrent Opinion in Plant Biology, 2000
- Herb-drug interactionsThe Lancet, 2000
- Effects of Food on Clinical PharmacokineticsClinical Pharmacokinetics, 1999
- Isoachifolidien, eine Vorstufe von Guaianolid-Peroxiden ausAchillea millefolium1Planta Medica, 1992
- Hypericin content variation in Hypericum perforatum in AustraliaPhytochemistry, 1991